We are live on ! Find out more
CMBA

C.M. Bidwell & Associates Portfolio holdings

AUM $245M
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
+0.84%
1 Year Est. Return
+23.8%
3 Year Est. Return
+70.62%
5 Year Est. Return
+83.19%
10 Year Est. Return
+679.91%
AUM
$165M
AUM Growth
+$994K
Cap. Flow
+$1.37M
Cap. Flow %
0.83%
Top 10 Hldgs %
38.18%
Holding
544
New
44
Increased
65
Reduced
121
Closed
59

Top Buys

Rank Stock Value
1
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$724K
2
GVI icon
iShares Intermediate Government/Credit Bond ETF
GVI
+$698K
3
SCHO icon
Schwab Short-Term US Treasury ETF
SCHO
+$475K
4
TSLA icon
Tesla
TSLA
+$398K
5
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$351K

Top Sells

Rank Stock Value
1
SCHP icon
Schwab US TIPS ETF
SCHP
+$556K
2
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$531K
3
HOOD icon
Robinhood
HOOD
+$345K
4
LLY icon
Eli Lilly
LLY
+$341K
5
CBOE icon
Cboe Global Markets
CBOE
+$299K

Sector Composition

Rank Sector Weight
1 Technology 6.4%
2 Financials 3.15%
3 Consumer Discretionary 2.92%
4 Communication Services 2.86%
5 Healthcare 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
U icon
476
Unity
U
$19.4B
$225 ﹤0.01%
10
-82
-89% -$1.82K
FTRE icon
477
Fortrea Holdings
FTRE
$1.78B
$205 ﹤0.01%
11
– –
PACB icon
478
Pacific Biosciences
PACB
$336M
$176 ﹤0.01%
96
-220
-70% -$429
TXG icon
479
10x Genomics
TXG
$7.52B
$172 ﹤0.01%
12
-60
-83% -$947
NTLA icon
480
Intellia Therapeutics
NTLA
$1.7B
$140 ﹤0.01%
12
– –
TDOC icon
481
Teladoc Health
TDOC
$1.2B
$136 ﹤0.01%
15
-71
-83% -$686
DNA icon
482
Ginkgo Bioworks
DNA
$500M
$49 ﹤0.01%
5
– –
FATE icon
483
Fate Therapeutics
FATE
$325M
$49 ﹤0.01%
30
– –
TSP
484
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$26 ﹤0.01%
66
– –
ADI icon
485
Analog Devices
ADI
$188B
– –
-20
Closed -$4.6K
AEO icon
486
American Eagle Outfitters
AEO
$2.75B
– –
-24
Closed -$537
AMGN icon
487
Amgen
AMGN
$226B
– –
-14
Closed -$4.51K
ARW icon
488
Arrow Electronics
ARW
$10.7B
– –
-25
Closed -$3.32K
ASPN icon
489
Aspen Aerogels
ASPN
$501M
– –
-22
Closed -$609
BTG icon
490
B2Gold
BTG
$6.82B
– –
-1,582
Closed -$4.87K
BTU icon
491
Peabody Energy
BTU
$2.97B
– –
-127
Closed -$3.37K
CB icon
492
Chubb
CB
$134B
– –
-13
Closed -$3.75K
CBOE icon
493
Cboe Global Markets
CBOE
$29.8B
– –
-1,459
Closed -$299K
CCS icon
494
Century Communities
CCS
$2B
– –
-37
Closed -$3.81K
CELH icon
495
Celsius Holdings
CELH
$6.99B
– –
-821
Closed -$25.7K
CL icon
496
Colgate-Palmolive
CL
$74B
– –
-42
Closed -$4.36K
CMRE icon
497
Costamare
CMRE
$1.71B
– –
-219
Closed -$3.44K
DAN icon
498
Dana Inc
DAN
$3.2B
– –
-371
Closed -$3.92K
DAWN
499
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-28
Closed -$390
DIS icon
500
Walt Disney
DIS
$178B
– –
-38
Closed -$3.65K
18 19
20
21 22

Similar funds

LHCM
Lloyd Harbor Capital Management Cold Spring Harbor, New York $245M AUM 141.83% 1-Year Est. Return
JP
JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $244M AUM
BNMT
Bawa N Mallick Trust Forest Hills, New York $244M AUM 19.8% 1-Year Est. Return
KC
Kinloch Capital Glen Allen, Virginia $245M AUM 18.26% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return

C.M. Bidwell & Associates's Q4 2024 Portfolio in Review

As of Q4 2024, C.M. Bidwell & Associates held 544 positions worth $165M, up 0.61% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

C.M. Bidwell & Associates's Q4 2024 filing shows 44 new, 65 increased, 121 reduced and 59 closed positions. Its largest new stake was Gilead Sciences: 3,801 shares worth $351K. The largest sale was Schwab US TIPS ETF, an estimated $556K.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, up from 6.4% a quarter earlier, followed by Financials and Consumer Discretionary.

  • C.M. Bidwell & Associates's largest Q4 2024 buy was Gilead Sciences: 3,801 shares worth $351K.
  • C.M. Bidwell & Associates added most to Vanguard Short-Term Bond ETF in Q4 2024, an estimated $724K increase.
  • C.M. Bidwell & Associates's biggest Q4 2024 reduction was Schwab US TIPS ETF, cutting an estimated $556K.
  • C.M. Bidwell & Associates fully exited Eli Lilly in Q4 2024, selling an estimated $341K.
  • C.M. Bidwell & Associates's ten largest holdings make up 38% of its $165M portfolio in Q4 2024.
  • C.M. Bidwell & Associates opened 44 new positions and closed 59 in Q4 2024.
  • C.M. Bidwell & Associates's portfolio value rose 0.61% quarter-over-quarter to $165M.

Based on C.M. Bidwell & Associates's 13F filing for Q4 2024, filed 12 Feb 2025.